| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 26,231 | 30,780 | 33,403 | | Cost of Revenue | 12,200 | 13,189 | 15,277 | | | Gross Profit | 14,031 | 17,591 | 18,126 | | | Operating Expenses | | Research Development | 9,198 | 10,216 | 8,226 | | Selling General and Administrative | 9,337 | 10,306 | 9,331 | | Non Recurring | 403 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,907) | (2,931) | 569 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 618 | 1,128 | 1,112 | | Earnings Before Interest And Taxes | (4,289) | (1,803) | 1,681 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (4,289) | (1,803) | 1,681 | | Income Tax Expense | (1,263) | (609) | (405) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,026) | (1,194) | 2,086 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (3,026) | (1,194) | 2,086 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,026) | ($1,194) | $2,086 |
|
1.23% Nasdaq 
Income Statement
